Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock.
The Armenian Reporter3 天
Evoke Pharma (NASDAQ:EVOK) Stock Price Crosses Below Two Hundred Day Moving Average ...
Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.93 and traded as low as $4.35.